Ultralife Corporation (ULBI) Q2 2026 Earnings Call Summary

1Key Financial Results and Metrics

Revenue: $47.9 million, a decrease from $48.6 million in Q2 2025.

Operating Profit: $3.4 million, up from $2.3 million year-over-year.

Earnings Per Share (EPS): $0.15, compared to $0.05 in Q2 2025.

Gross Profit: $13.9 million, a 19.5% increase year-over-year; gross margin improved to 28.9% from 23.9%.

Backlog: Record high of $117.5 million, a 39% increase from the previous year.

Adjusted EBITDA: $6.1 million (12.8% of sales), up from $4.1 million (8.5% of sales) in the prior year.

2Strategic Updates and Business Highlights

Product Development: Continued investment in new products, particularly in the Communications Systems segment, with several new releases planned.

Operational Improvements: New plant leaders are driving gross margin initiatives, with positive impacts expected from operational improvements.

Market Positioning: The company is consolidating under the Ultralife Master brand to enhance customer messaging and market presence.

Defense Spending Alignment: The product portfolio aligns well with current defense spending trends, particularly in modernization and network capabilities.

3Forward Guidance and Outlook

Growth Initiatives: Management is focused on accelerating revenue capture in Communications Systems, improving gross margins, and expanding vertical integration post-Electrochem acquisition.

Future Revenue: Anticipated growth in customer demand for battery products, with expectations for significant revenue contributions from new product launches and ongoing development programs.

Backlog Growth: The backlog has increased to nearly $130 million as of July, indicating strong order pull-through.

4Bad News, Challenges, or Points of Concern

Revenue Decline: Overall revenue decreased year-over-year, with a notable decline in commercial sales (down 4.7%), particularly in the oil and gas sector due to geopolitical factors.

Operating Expenses: Increased by 10.6%, driven by higher new product development costs and one-time litigation expenses.

Dependence on Defense Contracts: The company faces risks related to potential reductions in government defense spending and uncertainties in global economic conditions that could impact future revenues.

5Notable Q&A Insights

Backlog and Orders: Management indicated that the backlog has seen significant growth since the end of Q2, reaching nearly $130 million, bolstered by order pull-through.

Product Insights: There was discussion about the Falcon Manpack order from L3Harris, with management unable to confirm how it would affect their divisions at this time.

Product Performance: Reports from tests conducted on Hewlett Packard Enterprise servers indicated successful performance under extreme conditions, which is crucial for military applications. Overall, Ultralife Corporation's Q2 2026 results reflect a mix of positive operational improvements and strategic initiatives, alongside challenges related to revenue declines in certain segments and increased operating costs. The company remains optimistic about future growth driven by a strong backlog and ongoing product development.